Skip to content

Based on multidimensional quantification of liver stagnation and spleen deficiency syndrome of hyperlipidemia TCM syndrome waiting diagnosis model

Based on multidimensional quantification of liver stagnation and spleen deficiency syndrome of hyperlipidemia TCM syndrome waiting diagnosis model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000650
Enrollment
Unknown
Registered
2024-11-03
Start date
2022-05-08
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipidemia

Interventions

healthy controls:None
Non-Liver depression and spleen deficiency hyperlipidemia group:none
Liver depression and spleen deficiency hyperlipidemia group:none

Sponsors

First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of Western medicine for primary hyperlipidemia. 1) Diagnosis: After fasting for more than 12 hours on a normal diet the appropriate range of serum TC is 2.26mmol/L (200mg/dl) were marginal increases. The appropriate range of serum LDL-C was < 3.37mmol/L(130mg/dl)3.37 to 4.12mmol/L(130 to 159mg/dl) was borderline elevated and =4.14mmol/L (60mg/dl) was elevated. bloodThe appropriate range of HDL-C was =1.04mmol/L (40mg/dl) =1.55mmol/L (60mg/dl) was an increase and <1.04mmol/L (40mg/dl) was a decrease. (2) All patients who voluntarily participated in this study (signed informed consent) were included. (3) People aged 30-70 years old.

Exclusion criteria

Exclusion criteria: (1) Secondary hyperlipidemia patients. (2) During the investigation period patients with acute diseases such as cold and acute gastroenteritis which interfered with the diagnosis of syndromes could not be included. (3) Patients with cerebral infarction myocardial infarction and other serious diseases mental illness unable to cooperate with the investigation.

Design outcomes

Primary

MeasureTime frame
Total cholesterol;

Secondary

MeasureTime frame
Triglyceride;Apolipoprotein B;High density lipoprotein;Apolipoprotein A-?;low density lipoprotein cholesterol;

Countries

China

Contacts

Public ContactXue feifei

601 Huangpu Avenue West Shipai Street Tianhe District Guangzhou City Guangdong Province

2523329776@qq.com139 2419 9196

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026